Anti Cancer Injection and Tablets

Lenmid 25Mg Tablet is used to treat anemia, which occurs in patients suffering from myelodysplastic syndrome (MDS). The drug is used in combination with certain other medicines in the treatment of multiple myeloma (MM). Some patients suffering from mantle cell lymphoma (MCL) may also receive Lenmid 25Mg Tablet treatment, as it is an immunomuodulator

Treosulfan is a chemotherapy drug used to treat ovarian cancer. It can also be used to treat other types of cancer when other treatments are no longer working. Treosulfan is an alkylating agent. It works by sticking to one of the cancer cell's DNA strands. Then the cell can't divide into 2 new cells.

Renodapt Tablet??is used for Immunosuppressive, Immunosuppressant, Anti transplant rejection, Prophylaxis of renal or cardiac rejection and other conditions. Renodapt Tablet contains??Mycophenolate Mofetil??as an active ingredient.Renodapt Tablet works by inhibiting DNA synthesis in immune cells thus helps in avoiding organ transplant rejection.

Etopa 100mg Injection is used in the treatment of small cell lung cancer and testicular cancer.

Etopa 100mg Injection is an anti-cancer medication. It works by damaging the genetic material (DNA) of the cancer cells and stops their growth and multiplication.

We are the leading Supplier and exporter of Cancer Cure Medicines for Treatment of all kind of cancers through out the body part.

Xpreza 100mg Powder for Injection is used in the treatment of ovarian cancer, head and neck cancer, cervical cancer, Testicular cancer., breast cancer, non-Hodgkin lymphoma (NHL), blood cancer, lung cancer, bone cancer and urinary bladder cancer.

Xpreza 100mg Powder for Injection interferes with the growth of DNA and RNA of the cancer cells by substituting their building blocks. It prevents the cancer cells from growing and multiplying.

Advacan 0.5mg Tablet is used in breast cancer, pancreatic cancer, lung cancer and kidney cancer.

Advacan 0.5mg Tablet suppresses the activity of body's immune system and prevents rejection of the transplanted organ.

Bortezomib¿¿is an anti-cancer drug and the first therapeutic proteasome inhibitor to be used in humans. Proteasomes are cellular complexes that break down proteins. In some cancers, the proteins that normally kill cancer cells are broken down too quickly. Bortezomib interrupts this process and lets those proteins kill the cancer cells. Also used to treating relapsed multiple myeloma and mantle cell lymphoma.

Bryxta 400mg Injection is used in the treatment of cancer of colon and rectum, breast cancer, non-small cell lung cancer, ovarian cancer, cancer of fallopian tube and kidney cancer. It is also used to treat eye diseases like wet form of age-related macular degeneration and diabetic macular edema. Bryxta 400mg Injection is a monoclonal antibody. It works in cancer by stopping the formation of blood vessels that bring oxygen and nutrients to cancerous cells. This may slow the growth and spread of cancer. It works in eye diseases by stopping abnormal blood vessel growth and leakage in the eye(s), thereby preventing from vision loss.

Renodapt 500 mg Tablet is used for prevention of organ rejection in transplant patients. Renodapt 500 mg Tablet is an immunosuppressant. It reduces the action of body's own defense system (the immune system) and prevents rejection of the transplanted organ.

Erlonat 150 mg Tablet is used in the treatment of non-small cell lung cancer and pancreatic cancer. Erlonat 150 mg Tablet is an anti-cancer medication. It works by blocking the action of the abnormal protein that signals cancer cells to multiply. This helps to stop or slow the spread of cancer cells.

Capnat 500 mg Tablet is used in the treatment of breast cancer.  Capecitabine 500 mg Tablet is an anticancer medication. It works by interfering with the growth of genetic material (DNA and RNA) of the cancer cells. This slows the growth of cancer cells and eventually kills them.

Biomab Egfr 50mg Injection 10ML is used in the treatment of head and neck cancerand cancer of colon and rectum.

Biomab Egfr 50mg Injection 10ML is a monoclonal antibody that specifically binds to receptors on cancer cells. Thus it flags the cancer cells for destruction by the body's immune system.

We are drop shipping service provider to across globe for all kind of cancer medicines (Branded as well as generic medicines).

Methotrexate, formerly known as amethopterin, is a chemotherapy agent and immune system suppressant. It is used to treat cancer, autoimmune diseases, ectopic pregnancy. Types of cancers it is used for include breast cancer, leukemia, lung cancer, lymphoma, and osteosarcoma. Types of autoimmune diseases it is used for include psoriasis, rheumatoid arthritis, and Crohn's disease. It can be given by mouth or by injection.

Duprost capsules 0.5mg are used to treat benign prostatic hyperplasia (BPH), which is an enlarged prostate gland.  Duprost capsules 0.5mg help to shrink the prostate and reduce the risk of urinary retention caused by restricted urine flow as the prostate gland becomes enlarged and presses against the urethra (urine outlet tube from the bladder), which helps urine to flow more easily, prevents urine backlog in the bladder and restores bladder control. This relieves symptoms like need for frequent urination, inability to empty the bladder, strain and difficulty passing urine. The improved urine flow and reduction in symptoms may reduce the need for surgery due to moderate to severe symptoms of BHP. As a side effect of its intended use, Duprost capsules 0.5mg are also used to treat male pattern hair loss (androgenetic alopecia) by increasing hair growth and preventing further hair loss from all areas of the scalp, including the front.  This can reverse balding in men with mild to moderate hair loss but does not restore hair that has been lost for a long time.  Duprost capsules 0.5mg are not used to treat hair loss in women.

CARFILNAT(TM) is a proteasome inhibitor indicated for the treatment of patients with multiple myeloma who have received at least two prior therapies including bortezomib and an immunomodulatory agent and have demonstrated disease progression on or within 60 days of completion of the last therapy.